JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB153673

Anti-galectin 9/Gal-9 antibody [1G3]

4

(2 Reviews)

|

(12 Publications)

Mouse Monoclonal galectin 9/Gal-9 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 12 publications.

View Alternative Names

Galectin-9, Gal-9, Ecalectin, Tumor antigen HOM-HD-21, LGALS9

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-galectin 9/Gal-9 antibody [1G3] (AB153673)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-galectin 9/Gal-9 antibody [1G3] (AB153673)

IHC image of galectin 9/Gal-9 staining in Human normal Tonsil formalin fixed paraffin embedded tissue section*, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab153673, 5μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre

Western blot - Anti-galectin 9/Gal-9 antibody [1G3] (AB153673)
  • WB

Lab

Western blot - Anti-galectin 9/Gal-9 antibody [1G3] (AB153673)

All lanes:

Western blot - Anti-galectin 9/Gal-9 antibody [1G3] (ab153673) at 5 µg/mL

Lane 1:

HeLa transfected with galectin 9 / Gal-9 whole cell lysate at 10 µg

Lane 2:

HeLa (wild type control) whole cell lysate at 10 µg

Secondary

All lanes:

Goat anti-mouse IgG polyclonal antibody (HRP conjugated) at 1/10000 dilution

Predicted band size: 40 kDa

Observed band size: 18 kDa,35 kDa

true

Exposure time: 30s

Western blot - Anti-galectin 9/Gal-9 antibody [1G3] (AB153673)
  • WB

CiteAb

Western blot - Anti-galectin 9/Gal-9 antibody [1G3] (AB153673)

galectin 9/Gal-9 western blot using anti-galectin 9/Gal-9 antibody [1G3] ab153673. Publication image and figure legend from Barjon, C., Niki, T., et al., 2012, Infect Agent Cancer, PubMed 22805533.

ab153673 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab153673 please see the product overview.

Western blot detection of galectin-9 isoforms using the 1G3 monoclonal antibody. A low amount of S and M galectin-9 isoforms are present in wild-type HeLa cells. These isoforms are readily detected following transfection with the appropriate expression plasmids. The L-isoform is expressed at a lower abundance than the two other forms. The three endogenous isoforms are detected in the protein extracts from the C15 and C666-1 NPC xenografts. The EBV-positive B-cell line REMB1 expresses a high amount of the M-isoform and a very low amount of L-isoform, however no S-isoform could be detected. In contrast with REMB1 cells, the BL2 cells derived from an EBV-negative B-cell lymphoma have no detectable galectin-9. The faint background bands visible after long exposure do not match with any galectin-9 isoform.

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

1G3

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody fails to detect endogenous natural samples in WB.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-5 µg/mL", "WB-species-notes": "<p></p>" } } }

Product details

Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

Properties and storage information

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Galectin-9 also known as Gal-9 or LGALS9 is a β-galactoside-binding lectin with a molecular mass of around 40 kDa. It shows expression in various tissues including the thymus spleen and liver. The galectin-9 protein is involved in cell-cell and cell-matrix interactions where it binds to glycoproteins and glycolipids. Researchers commonly use methods like Galectin-9 ELISA to measure its levels in different biological samples.
Biological function summary

Galectins like galectin-9 play essential roles in regulating diverse immune responses. Galectin-9 acts within the immune system by modulating inflammation and apoptosis. It acts as both a pro-apoptotic factor for T cells and a protein mediator in innate immune functions. Galectin-9 proteins can form complexes with other lectins and cell surface receptors contributing to cellular signaling processes.

Pathways

Galectin-9 is integral to the immune system's functional networks. It participates in the T-cell regulation pathways and the innate immunity pathways. In these pathways it interacts with other proteins like TIM-3 which mediates T-cell apoptosis and contributes to immune tolerance. These interaction networks play important roles in maintaining the body's immune homeostasis.

Galectin-9 has associations with autoimmune diseases and cancer. Its regulatory effects on T cells connect it to autoimmune conditions where abnormal T-cell activation occurs. In cancer the alteration in galectin-9 expression levels affects tumor immunity. The interaction of galectin-9 with other proteins like TIM-3 is important in cancer progression making it a target of interest for therapeutic interventions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Binds galactosides (PubMed : 18005988). Has high affinity for the Forssman pentasaccharide (PubMed : 18005988). Ligand for HAVCR2/TIM3 (PubMed : 16286920). Binding to HAVCR2 induces T-helper type 1 lymphocyte (Th1) death (PubMed : 16286920). Also stimulates bactericidal activity in infected macrophages by causing macrophage activation and IL1B secretion which restricts intracellular bacterial growth (By similarity). Ligand for P4HB; the interaction retains P4HB at the cell surface of Th2 T-helper cells, increasing disulfide reductase activity at the plasma membrane, altering the plasma membrane redox state and enhancing cell migration (PubMed : 21670307). Ligand for CD44; the interaction enhances binding of SMAD3 to the FOXP3 promoter, leading to up-regulation of FOXP3 expression and increased induced regulatory T (iTreg) cell stability and suppressive function (By similarity). Promotes ability of mesenchymal stromal cells to suppress T-cell proliferation (PubMed : 23817958). Expands regulatory T-cells and induces cytotoxic T-cell apoptosis following virus infection (PubMed : 20209097). Activates ERK1/2 phosphorylation inducing cytokine (IL-6, IL-8, IL-12) and chemokine (CCL2) production in mast and dendritic cells (PubMed : 16116184, PubMed : 24465902). Inhibits degranulation and induces apoptosis of mast cells (PubMed : 24465902). Induces maturation and migration of dendritic cells (PubMed : 16116184, PubMed : 25754930). Inhibits natural killer (NK) cell function (PubMed : 23408620). Can transform NK cell phenotype from peripheral to decidual during pregnancy (PubMed : 25578313). Astrocyte derived galectin-9 enhances microglial TNF production (By similarity). May play a role in thymocyte-epithelial interactions relevant to the biology of the thymus. May provide the molecular basis for urate flux across cell membranes, allowing urate that is formed during purine metabolism to efflux from cells and serving as an electrogenic transporter that plays an important role in renal and gastrointestinal urate excretion (By similarity). Highly selective to the anion urate (By similarity).. Isoform 2. Acts as an eosinophil chemoattractant (PubMed : 9642261). It also inhibits angiogenesis (PubMed : 24333696). Suppresses IFNG production by natural killer cells (By similarity).
See full target information LGALS9

Publications (12)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 15:1302761 PubMed38390332

2024

Immune checkpoint ligands expressed on mature high endothelial venules predict poor prognosis of NSCLC: have a relationship with CD8 T lymphocytes infiltration.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Luo,Xiuhuan Shi,Yumeng Liu,Jian Wang,Hao Wang,Xuena Yang,Qian Sun,Zhenzhen Hui,Feng Wei,Xiubao Ren,Hua Zhao

Acta pharmaceutica Sinica. B 13:2585-2600 PubMed37425040

2023

Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing mRNA.

Applications

Unspecified application

Species

Unspecified reactive species

Wenxin Zhang,Xiaohui Pan,Yanjun Xu,Hongjie Guo,Mingming Zheng,Xi Chen,Honghai Wu,Fengming Luan,Qiaojun He,Ling Ding,Bo Yang

The Journal of clinical investigation 133: PubMed36594471

2023

Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling.

Applications

Unspecified application

Species

Unspecified reactive species

Ling Ding,Xi Chen,Wenxin Zhang,Xiaoyang Dai,Hongjie Guo,Xiaohui Pan,Yanjun Xu,Jianguo Feng,Meng Yuan,Xiaomeng Gao,Jian Wang,Xiaqing Xu,Sicheng Li,Honghai Wu,Ji Cao,Qiaojun He,Bo Yang

Frontiers in genetics 13:981145 PubMed36531216

2022

Integrating cell interaction with transcription factors to obtain a robust gene panel for prognostic prediction and therapies in cholangiocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Tingjie Wang,Chuanrui Xu,Dan Xu,Xiaofei Yang,Yaxin Liu,Xiujuan Li,Zihang Li,Ningxin Dang,Yi Lv,Zhijing Zhang,Lei Li,Kai Ye

Frontiers in genetics 13:771344 PubMed35646093

2022

An Integrated Systematic Analysis and the Clinical Significance of Hepcidin in Common Malignancies of the Male Genitourinary System.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaogang Wang,Qianqian Shi,Pengfeng Gong,Cuixing Zhou,Yunjie Cao

Oncology letters 23:197 PubMed35572493

2022

Prognostic significance of the expression levels of T-cell immunoglobulin mucin-3 and its ligand galectin-9 for relapse-free survival in triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Katsuhiro Yoshikawa,Mitsuaki Ishida,Hirotsugu Yanai,Koji Tsuta,Mitsugu Sekimoto,Tomoharu Sugie

Modern pathology : an official journal of the Unit 33:1182-1192 PubMed32139873

2020

Looking past PD-L1: expression of immune checkpoint TIM-3 and its ligand galectin-9 in cervical and vulvar squamous neoplasia.

Applications

Unspecified application

Species

Unspecified reactive species

Jacob Curley,Mark R Conaway,Zachary Chinn,Linda Duska,Mark Stoler,Anne M Mills

OncoTargets and therapy 12:10099-10105 PubMed31819504

2019

PD-L1 Expression Is Regulated By NF-κB During EMT Signaling In Gastric Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Dan Xu,Jing Li,Rui-Yang Li,Ting Lan,Chi Xiao,Ping Gong

The Journal of pathology 245:468-477 PubMed29732570

2018

CD206-positive myeloid cells bind galectin-9 and promote a tumor-supportive microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Elizabeth Ann L Enninga,Kyriakos Chatzopoulos,John T Butterfield,Shari L Sutor,Alexey A Leontovich,Wendy K Nevala,Thomas J Flotte,Svetomir N Markovic

Journal of virology 92: PubMed29695422

2018

Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20.

Applications

Unspecified application

Species

Unspecified reactive species

Junjie Feng,Arthur Wickenhagen,Matthew L Turnbull,Veronica V Rezelj,Felix Kreher,Natasha L Tilston-Lunel,Gillian S Slack,Benjamin Brennan,Elina Koudriakova,Andrew E Shaw,Suzannah J Rihn,Charles M Rice,Paul D Bieniasz,Richard M Elliott,Xiaohong Shi,Sam J Wilson
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com